Brains of Smokers Show More Signs of Atrophy

JANUARY 15, 2013
Cigarette smoking may contribute to brain deterioration and abnormalities associated with the early stages of Alzheimer’s disease, according to a recent study published in the November 2012 issue of Alzheimer’s & Dementia, the journal of the Alzheimer’s Association.

Researchers studied 186 healthy elderly subjects who served as control subjects in the Alzheimer Disease Neuroimaging Initiative project. Participants were organized into 2 groups at the beginning of the study: smokers and nonsmokers. Researchers collected data throughout the study on the subjects’ smoking history. Participants completed 4 magnetic resonance scans over 2 years and the researchers analyzed any changes in regional brain volume.

Smokers had a significantly greater rate of atrophy over the 2-year period than nonsmokers in multiple areas of the brain connected to the early stages of Alzheimer’s disease. Smokers demonstrated greater atrophy rates in areas of the brain used for learning, memory, and the processing of complex visual social and emotional signals.

Researchers also found a higher rate of deterioration in smokers than nonsmokers in the extended brain reward/executive oversight system, which is associated with substance abuse.

The researchers conclude that if the increased rate of deterioration recorded over the 2 years continues, these individuals may have an increased risk of neurocognitive dysfunction. They suggest that more research be done to study the rate of atrophy beyond 2 years and its implications.

For more articles in this watch, please see:
Orientation May Serve as New Diagnosis Criterion
Parkinson’s Disease Patients Demonstrate High Risk for Dementia



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.